The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study

Abstract Antipsychotic medication forms a cornerstone in the treatment of schizophrenia and its effect on positive symptoms and relapse prevention after the first episode has been shown. After the first episode, the treatment guidelines for schizophrenia recommend the continuation of antipsychotic m...

Full description

Bibliographic Details
Main Author: Moilanen, J. (Jani)
Other Authors: Isohanni, M. (Matti), Miettunen, J. (Jouko), Koponen, H. (Hannu)
Format: Doctoral or Postdoctoral Thesis
Language:English
Published: Oulun yliopisto 2016
Subjects:
Online Access:http://urn.fi/urn:isbn:9789526212067
id ftunivoulu:oai:oulu.fi:isbn978-952-62-1206-7
record_format openpolar
spelling ftunivoulu:oai:oulu.fi:isbn978-952-62-1206-7 2023-07-30T04:05:50+02:00 The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study Moilanen, J. (Jani) Isohanni, M. (Matti) Miettunen, J. (Jouko) Koponen, H. (Hannu) 2016-05-17 application/pdf http://urn.fi/urn:isbn:9789526212067 eng eng Oulun yliopisto info:eu-repo/semantics/altIdentifier/pissn/0355-3221 info:eu-repo/semantics/altIdentifier/eissn/1796-2234 info:eu-repo/semantics/openAccess © University of Oulu, 2016 antipsychotics brain morphometry outcome schizophrenia aivomorfometria ennuste psykoosilääke skitsofrenia info:eu-repo/semantics/doctoralThesis info:eu-repo/semantics/publishedVersion 2016 ftunivoulu 2023-07-08T19:53:48Z Abstract Antipsychotic medication forms a cornerstone in the treatment of schizophrenia and its effect on positive symptoms and relapse prevention after the first episode has been shown. After the first episode, the treatment guidelines for schizophrenia recommend the continuation of antipsychotic medication at a minimum from six months to five years. The long-term and life-span benefits and harmful side-effects are not fully known. The aim of this naturalistic study was to analyze long-term use of antipsychotic medication with a special interest in medication tapering and discontinuation in schizophrenia. Non-medicated subjects were more often males and in remission, less often on a disability pension, and had better clinical outcomes when compared to medicated subjects at age 34 years. No differences were found when comparing relapse rates during the 8.7 years of follow-up after 34 years between non-medicated and medicated subjects. Not having been hospitalized during the previous 5 years before the follow-up predicted long-term successful antipsychotic discontinuation without relapse. In the long-term, use of antipsychotic medication became steadier after the first five years. A favorable outcome was associated with low and steady antipsychotic medication, and unfavorable with high long-term cumulative use and antipsychotic polypharmacy. Subjects with antipsychotic medication had non-significantly lower total gray matter (TGM) volume compared with non-medicated subjects. Time without antipsychotic medication preceding magnetic resonance imaging was associated with increased TGM and with increased regional volume in the right precentral gyrus and right middle frontal gyrus. This study has a unique description of long-term use of antipsychotics. It provides new information on medication discontinuation and its effect in schizophrenia in the long-term in terms of relapses and brain morphometry. Tiivistelmä Psykoosilääkkeet muodostavat perustan skitsofrenian hoidolle, ja niiden on osoitettu tehoavan ... Doctoral or Postdoctoral Thesis Northern Finland Jultika - University of Oulu repository
institution Open Polar
collection Jultika - University of Oulu repository
op_collection_id ftunivoulu
language English
topic antipsychotics
brain morphometry
outcome
schizophrenia
aivomorfometria
ennuste
psykoosilääke
skitsofrenia
spellingShingle antipsychotics
brain morphometry
outcome
schizophrenia
aivomorfometria
ennuste
psykoosilääke
skitsofrenia
Moilanen, J. (Jani)
The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study
topic_facet antipsychotics
brain morphometry
outcome
schizophrenia
aivomorfometria
ennuste
psykoosilääke
skitsofrenia
description Abstract Antipsychotic medication forms a cornerstone in the treatment of schizophrenia and its effect on positive symptoms and relapse prevention after the first episode has been shown. After the first episode, the treatment guidelines for schizophrenia recommend the continuation of antipsychotic medication at a minimum from six months to five years. The long-term and life-span benefits and harmful side-effects are not fully known. The aim of this naturalistic study was to analyze long-term use of antipsychotic medication with a special interest in medication tapering and discontinuation in schizophrenia. Non-medicated subjects were more often males and in remission, less often on a disability pension, and had better clinical outcomes when compared to medicated subjects at age 34 years. No differences were found when comparing relapse rates during the 8.7 years of follow-up after 34 years between non-medicated and medicated subjects. Not having been hospitalized during the previous 5 years before the follow-up predicted long-term successful antipsychotic discontinuation without relapse. In the long-term, use of antipsychotic medication became steadier after the first five years. A favorable outcome was associated with low and steady antipsychotic medication, and unfavorable with high long-term cumulative use and antipsychotic polypharmacy. Subjects with antipsychotic medication had non-significantly lower total gray matter (TGM) volume compared with non-medicated subjects. Time without antipsychotic medication preceding magnetic resonance imaging was associated with increased TGM and with increased regional volume in the right precentral gyrus and right middle frontal gyrus. This study has a unique description of long-term use of antipsychotics. It provides new information on medication discontinuation and its effect in schizophrenia in the long-term in terms of relapses and brain morphometry. Tiivistelmä Psykoosilääkkeet muodostavat perustan skitsofrenian hoidolle, ja niiden on osoitettu tehoavan ...
author2 Isohanni, M. (Matti)
Miettunen, J. (Jouko)
Koponen, H. (Hannu)
format Doctoral or Postdoctoral Thesis
author Moilanen, J. (Jani)
author_facet Moilanen, J. (Jani)
author_sort Moilanen, J. (Jani)
title The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study
title_short The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study
title_full The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study
title_fullStr The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study
title_full_unstemmed The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study
title_sort use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the northern finland birth cohort 1966 study
publisher Oulun yliopisto
publishDate 2016
url http://urn.fi/urn:isbn:9789526212067
genre Northern Finland
genre_facet Northern Finland
op_relation info:eu-repo/semantics/altIdentifier/pissn/0355-3221
info:eu-repo/semantics/altIdentifier/eissn/1796-2234
op_rights info:eu-repo/semantics/openAccess
© University of Oulu, 2016
_version_ 1772818080676708352